PR Newswire Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD) by Money Compass May 4, 2026
PR Newswire SINTRONES to Demonstrate Secure Edge AI for Industrial, Mobility, and Mission-Critical Applications by Money Compass April 1, 2026
PR Newswire Webull Australia Moves to $0 Commission for International Trades. by Money Compass April 1, 2026
PR Newswire Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands by Money Compass April 1, 2026
PR Newswire Arclin Completes Acquisition of the DuPont™ Aramids Business, Including Iconic Kevlar® and Nomex® Brands by Money Compass April 1, 2026
PR Newswire Zeus Expands Access to Catheter Components Through Chamfr Marketplace by Money Compass April 1, 2026
PR Newswire NCCN 2026 Annual Conference Prepares Cancer Care Providers Worldwide for Healing the Whole Patient by Money Compass April 1, 2026
PR Newswire NCCN 2026 Annual Conference Prepares Cancer Care Providers Worldwide for Healing the Whole Patient by Money Compass April 1, 2026
